PRELIMINARY RESULTS OF NIRAPARIB AND BRIVANIB DUAL THERAPY EVALUATION IN RECURRENT, METASTATIC AND PERSISTENT CERVICAL CANCER (CQGOG0101: AN OPEN-LABEL, SINGLE ARM, PHASE II CLINICAL TRIAL

Authors
Category Primary study
JournalINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Year 2021
This article has no abstract
Epistemonikos ID: 187c9d93215c50d58833a1630aee4abf946251dc
First added on: Feb 13, 2025